Inovio Pharmaceuticals
INO
#8791
Rank
S$0.20 B
Marketcap
S$2.93
Share price
-0.22%
Change (1 day)
20.83%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): S-$3.73

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S-$3.71. In 2024 the company made an earnings per share (EPS) of S-$5.09 an increase over its 2023 EPS that were of S-$7.85.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$3.73-26.79%
2024S-$5.09-35.14%
2023S-$7.85-56.62%
2022S-$18.09-19.54%
2021S-$22.4935.9%
2020S-$16.55-11.57%
2019S-$18.7115.24%
2018S-$16.24-2.78%
2017S-$16.706.93%
2016S-$15.62134.88%
2015S-$6.65-29.51%
2014S-$9.43-57.34%
2013S-$22.11146.55%
2012S-$8.9720.83%
2011S-$7.42-29.41%
2010S-$10.51-48.48%
2009S-$20.4110%
2008S-$18.5611.11%
2007S-$16.70-41.3%
2006S-$28.45-66.91%
2005S-$85.97110.61%
2004S-$40.82-61.63%
2003S-$106.38186.67%
2002S-$37.11
2001N/A-100%
2000S-$29.69-63.64%
1999S-$81.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$2.22-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$13.45-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S-$1.61-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.48-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$9.79-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$4.63-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
S$8.40-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA